Created in 1992, bioskin® is a leading dermatology CRO which plans and conducts clinical trials for drugs, medical devices, food supplements and advanced cosmetics. Headquartered in Germany bioskin...
Created in 1992, bioskin® is a leading dermatology CRO which plans and conducts clinical trials for drugs, medical devices, food supplements and advanced cosmetics. Headquartered in Germany bioskin® provides strategic and regulatory consulting for dermatology, ophthalmology and women's health products, early phase safety and Proof-of-Concept studies, vasoconstrictor assays and global Phase II-IV trials for NCEs, new formulations with known actives and generics. We maintain a large database of healthy volunteers and patients profiled for skin condition and disease, assuring fast, reliable recruitment. A core expertise is the development of innovative test models, integrating biophysical measurement methods to deliver objective data about skin function and structure to support traditional clinical endpoints. In addition, through an extensive network of dermatologists and university hospitals bioskin® has excellent access to patients outside of Germany, including challenging to find and severely diseased patients. bioskin® partners with select, reliable partners in the US, Latin America, EU, Eastern Europe and South Africa for the conduct of pivotal multinational studies.